Monash IVF Group
(ASX:MVF) has appointed a new Chief Executive Officer and Managing Director, Mr David Morris.
The assisted reproductive services provider, welcomes David Morris’ 20 years of leadership and 13 years at Cochlear Limited, having served as Chief Strategy Officer for the global hearing solutions company.
Having previously served as President of Cochlear Bone Anchored Solutions at Cochlear, the new CEO and Managing Director also comes with extensive strategic experience from his time at Accenture.
The new position will be effective from 13th November.
Shares in Monash IVF Group
(ASX:MVF) are trading 0.47 per cent higher at $1.61.
